Generics Top 5 Emerging Markets Industry Guide 2015-2024
The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
– These countries contributed $99,860.0 million to the global generics industry in 2019, with a compound annual growth rate (CAGR) of 8.9% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $130,298.8 million in 2024, with a CAGR of 5.5% over the 2019-24 period.
– Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of $69,811.0 million in 2019. This was followed by India and Mexico with a value of $16,448.5 and $6,634.9 million, respectively.
– China is expected to lead the generics industry in the top five emerging nations, with a value of $89,577.3 million in 2024, followed by India and Mexico with expected values of $23,292.4 and $8,408.8 million, respectively.
– Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five generics market
– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five generics market
– Leading company profiles reveal details of key generics market players’ emerging five operations and financial performance
– Add weight to presentations and pitches by understanding the future growth prospects of the emerging five generics market with five year forecasts by both value and volume
– Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to Buy
– What was the size of the emerging five generics market by value in 2019?
– What will be the size of the emerging five generics market in 2024?
– What factors are affecting the strength of competition in the emerging five generics market?
– How has the market performed over the last five years?
– How large is the emerging five generics market in relation to its regional counterparts?
Aspen Pharmacare Holdings Ltd
Teva Pharmaceutical Industries Limited
Adcock Ingram Holdings Ltd
Ache Laboratorios Farmaceuticos SA
Eurofarma Laboratorios SA
China Grand Pharmaceutical and Healthcare Holdings Limited
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma Ltd
For queries regarding this report: https://www.researchbymarkets.com/sample-request/645768